Singapore HSA registration DE0503602
Regen Lab Cellular Matrix BCT-HA Kit
Singapore·CLASS D·Regen Lab SA·Registered September 13, 2019Device classification
- Device Class
- CLASS D
- Medical Speciality Area
- Hematology
Registration information
- Registration Number
- DE0503602
- Registration Date
- September 13, 2019
- Change Notification Approval Date
- June 10, 2024
- Retention Due Date
- September 12, 2025
Product description
i. Hyaluronic acid (HA) for use as intra-articular injections for symptomatic treatment of articular pain and mobility improvement, or as intra-dermal injections for hydration of dehydrated and wrinkled skin tissues; and ii. Devices for use in the preparation of PRP with HA
Product Owner
- Name
- Regen Lab SA
- Short Name
- Regen Lab SA
- Address
- En Budron B2, 1052- Le Mont, SWITZERLAND
Registrant
- Address
- 111 NORTH BRIDGE ROAD, PENINSULA PLAZA, #21-01, SINGAPORE 179098
Importer
- Address
- 18 SIN MING LANE, MIDVIEW CITY, #06-17, SINGAPORE 573960
Model information
- Model Name(s)
- Cellular Matrix BCT-HA Kit
- Model Identifier(s)
- BCT-HA-3
About this record
Access comprehensive regulatory information for Regen Lab Cellular Matrix BCT-HA Kit in the Singapore medical device market through Pure Global AI's free database. This CLASS D medical device is registered under HSA registration number DE0503602 and owned by Regen Lab SA. The device was registered on September 13, 2019.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
Free DatabasePowered by Pure Global AIHSA Official DataCLASS D